The Labyrinth of Product Development and Regulatory Approvals in Liquid Biopsy Diagnostics

The evolution of chemistries and instrument platforms for next‐generation sequencing has led to sequencing of genomic variants in both tumor biopsies as well as in circulating tumor cells (CTCs) and cell‐free DNA liquid biopsies. The transition of these analytical platforms into clinical ones has le...

全面介紹

Saved in:
書目詳細資料
主要作者: Federico M. Goodsaid (Author)
格式: 圖書
出版: Wiley, 2019-09-01T00:00:00Z.
主題:
在線閱讀:Connect to this object online.
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

Connect to this object online.

3rd Floor Main Library

持有資料詳情 3rd Floor Main Library
索引號: A1234.567
復印件 1 可用